digital health startups weight loss glp-1 Virtual startups: Pill mills or the future of obesity care? GLP-1 Shortage = Over -

Let's explore the research and real-world data on the durability of weight loss achieved with GLP-1 analogue therapies and the vital role of lifestyle changes in maintaining results over time

Nationally recognized experts in their fields

All trials were multinational and sponsored by industry (two by Sanofi Aventis, three by Novo Nordisk, one by Eli Lilly, one by AstraZeneca, one by GlaxoSmithKline)

The lawsuit claims the manufacturer failed to adequately warn about the risk of serious gastrointestinal side effects

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies

Aguiar AF, Janurio RS, Junior RP, Gerage AM, Pina FL, do Nascimento MA, et al